chr1-5865311-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000460696.1(NPHP4):​n.1771C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.402 in 1,482,882 control chromosomes in the GnomAD database, including 122,548 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.35 ( 10196 hom., cov: 33)
Exomes 𝑓: 0.41 ( 112352 hom. )

Consequence

NPHP4
ENST00000460696.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.09

Publications

10 publications found
Variant links:
Genes affected
NPHP4 (HGNC:19104): (nephrocystin 4) This gene encodes a protein involved in renal tubular development and function. This protein interacts with nephrocystin, and belongs to a multifunctional complex that is localized to actin- and microtubule-based structures. Mutations in this gene are associated with nephronophthisis type 4, a renal disease, and with Senior-Loken syndrome type 4, a combination of nephronophthisis and retinitis pigmentosa. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2014]
NPHP4 Gene-Disease associations (from GenCC):
  • nephronophthisis 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Senior-Loken syndrome 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • nephronophthisis 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 1-5865311-G-A is Benign according to our data. Variant chr1-5865311-G-A is described in ClinVar as [Benign]. Clinvar id is 260559.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.415 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPHP4NM_015102.5 linkc.3645-38C>T intron_variant Intron 26 of 29 ENST00000378156.9 NP_055917.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPHP4ENST00000378156.9 linkc.3645-38C>T intron_variant Intron 26 of 29 1 NM_015102.5 ENSP00000367398.4 O75161-1
NPHP4ENST00000378169.7 linkn.*2546-38C>T intron_variant Intron 23 of 26 1 ENSP00000367411.3 D6RA06
NPHP4ENST00000489180.6 linkn.*1456-38C>T intron_variant Intron 29 of 32 2 ENSP00000423747.1 O75161-2

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53654
AN:
152066
Hom.:
10194
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.208
Gnomad AMI
AF:
0.551
Gnomad AMR
AF:
0.369
Gnomad ASJ
AF:
0.460
Gnomad EAS
AF:
0.268
Gnomad SAS
AF:
0.430
Gnomad FIN
AF:
0.427
Gnomad MID
AF:
0.392
Gnomad NFE
AF:
0.418
Gnomad OTH
AF:
0.362
GnomAD2 exomes
AF:
0.389
AC:
48526
AN:
124902
AF XY:
0.393
show subpopulations
Gnomad AFR exome
AF:
0.201
Gnomad AMR exome
AF:
0.368
Gnomad ASJ exome
AF:
0.474
Gnomad EAS exome
AF:
0.252
Gnomad FIN exome
AF:
0.439
Gnomad NFE exome
AF:
0.427
Gnomad OTH exome
AF:
0.410
GnomAD4 exome
AF:
0.408
AC:
542555
AN:
1330696
Hom.:
112352
Cov.:
29
AF XY:
0.409
AC XY:
264386
AN XY:
647122
show subpopulations
African (AFR)
AF:
0.199
AC:
6162
AN:
30994
American (AMR)
AF:
0.366
AC:
12400
AN:
33846
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
10025
AN:
21768
East Asian (EAS)
AF:
0.266
AC:
9382
AN:
35282
South Asian (SAS)
AF:
0.432
AC:
30507
AN:
70694
European-Finnish (FIN)
AF:
0.424
AC:
16910
AN:
39836
Middle Eastern (MID)
AF:
0.406
AC:
1654
AN:
4074
European-Non Finnish (NFE)
AF:
0.417
AC:
433336
AN:
1039052
Other (OTH)
AF:
0.402
AC:
22179
AN:
55150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
16088
32176
48265
64353
80441
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13890
27780
41670
55560
69450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.353
AC:
53673
AN:
152186
Hom.:
10196
Cov.:
33
AF XY:
0.355
AC XY:
26412
AN XY:
74398
show subpopulations
African (AFR)
AF:
0.208
AC:
8630
AN:
41542
American (AMR)
AF:
0.369
AC:
5651
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.460
AC:
1597
AN:
3470
East Asian (EAS)
AF:
0.268
AC:
1383
AN:
5166
South Asian (SAS)
AF:
0.430
AC:
2072
AN:
4818
European-Finnish (FIN)
AF:
0.427
AC:
4529
AN:
10598
Middle Eastern (MID)
AF:
0.395
AC:
116
AN:
294
European-Non Finnish (NFE)
AF:
0.418
AC:
28435
AN:
67978
Other (OTH)
AF:
0.359
AC:
759
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1776
3552
5328
7104
8880
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
528
1056
1584
2112
2640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.395
Hom.:
32735
Bravo
AF:
0.339
Asia WGS
AF:
0.376
AC:
1305
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 13, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nephronophthisis 4 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.84
DANN
Benign
0.54
PhyloP100
-2.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1287634; hg19: chr1-5925371; COSMIC: COSV65395132; COSMIC: COSV65395132; API